Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Oral Calcitriol on Proteinuria in Chronic Kidney Disease
IRCT20260520069463N1Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Aug 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of calcitriol in chronic kidney disease (CKD) and proteinuria (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Change in proteinuria. Started Aug 2026; status: recruiting.
02
Drugs
calcitriol
03
Conditions
chronic kidney disease (CKD)proteinuria
Beyond the preview
Go deeper on IRCT20260520069463N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260520069463N1.